B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Pentamidine

299 PubMed studies analyzed ยท 17 RCTs ยท Evidence Score: 46.9

Research Domains

Pentamidine has been studied across 15 research domains including ๐Ÿ”ฌ Oncology, ๐Ÿซ Liver & Detox, ๐Ÿซ˜ Kidney, ๐Ÿซ Respiratory, ๐Ÿง  Focus & Attention. The primary research focus is ๐Ÿ”ฌ Oncology with 10% of studies addressing this area.

Loading evidence profile...

This evidence profile for Pentamidine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.